The company

Lactest SL was constituted in 2003 on the base of the developments carried out in the Universidad Autónoma de Madrid and the Conselo Superior de Investigaciones Científicas (CSIC).

During these years they have developed a new methodology for the evaluation of the lactose intolerance, and have placed in motion the clinical trials development process, part already done, and has carried out the industrial scaled of the product.

 Lactest S.L. goal is to continue developing products to help the professionals in the diagnosis and monitoring the lactose intolerance.

Investors

 The company has three investors of the sector,

- The company of investments in biotechnology Cross Road Biotech
www.crossroadbiotech.com

- Ronda Vida venture capital funde
www.clavemayor.com

- The manufacturer of principal assets Proyachem S.L.

The other associates are scientists and the General Foundation of the Universidad Autónoma de Madrid. 

Team